Rare case of ocular adnexal relapse with mantle cell lymphoma treated with ibrutinib monotherapy

被引：2
|
作者：
Nishiyama-Fujita, Yuriko [1 ]
Nakazato, Tomonori [1 ]
Ito, Chisako [1 ]
Ogura, Shinji [1 ]
Mizuno, Kota [1 ]
Kamiya, Takahiro [1 ]
Aisa, Yoshinobu [1 ]
Mori, Takehiko [2 ]
机构：
[1] Yokohama Municipal Citizens Hosp, Dept Hematol, Yokohama, Kanagawa, Japan
[2] Keio Univ, Sch Med, Div Hematol, Tokyo, Japan
来源：
INTERNAL MEDICINE JOURNAL | 2019年 / 49卷 / 09期
关键词：
D O I：
10.1111/imj.14432
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1187 / 1189
页数：3
相关论文
共 50 条
  • [1] Mantle cell lymphoma in the ocular adnexal region
    Looi, A
    Gascoyne, RD
    Chhanabhai, M
    Connors, JM
    Rootman, J
    White, VA
    OPHTHALMOLOGY, 2005, 112 (01) : 114 - 119
  • [2] IBRUTINIB IN MANTLE LYMPHOMA IN RELAPSE IN SNC: ABOUT A CASE
    Navascues Javier, Cornago
    Moya Ana, Garcia-Noblejas
    Maria Jimena, Cannata Ortiz
    Yizel Elena, Paz Nunez
    Caballero Pedro, Parra
    Maria Reyes, Arranz Saez
    HAEMATOLOGICA, 2016, 101 : 227 - 228
  • [3] Mantle cell lymphoma of the iris treated by ibrutinib
    De Gauzy, T. Sales
    Oberic, L.
    Fournie, P.
    Soler, V.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2018, 41 (10): : E501 - E502
  • [4] Choroidal and Ocular Adnexal Lymphoma Extension From Systemic Mantle Cell Lymphoma: A Case Report
    Bou Ghanem, Ghazi O.
    Daye, Ghassan N.
    Saade, Marie Christelle W.
    Farhat, Jad H.
    Bejjani, Noha A.
    Saade, Michel J.
    Farhat, Hussein Z.
    Ghazi, Nicola G.
    HEMASPHERE, 2021, 5 (08): : E599
  • [5] Clinical characteristics and outcomes of ocular adnexal mantle cell lymphoma
    Becerra, Clara M. Castillejo
    Dalvin, Lauren A.
    Jevremovic, Dragan
    Hodge, David O.
    Tooley, Andrea A.
    ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2022, 41 (01): : 97 - 104
  • [6] Ibrutinib-Induced Uveitis: A Case of Rapid Ocular Toxicity in Mantle Cell Lymphoma
    Ramachandran, Sai Prasad
    Rayapureddi, Karthik
    Kriplani, Kushal
    Khurana, Harshit
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S518 - S518
  • [7] Ibrutinib for mantle cell lymphoma
    Tucker, David L.
    Rule, Simon A.
    FUTURE ONCOLOGY, 2016, 12 (04) : 477 - 491
  • [8] IBRUTINIB IN MONOTHERAPY AS A TREATMENT OF RELAPSED MANTLE CELL LYMPHOMA IN THE CENTRAL NERVOUS SYSTEM. CASE REPORT
    Morales de la Plaza, A.
    Santero Garcia, M.
    Sebrango Sadia, A.
    HAEMATOLOGICA, 2018, 103 : 337 - 337
  • [9] Activity of ibrutinib in mantle cell lymphoma patients with central nervous system relapse
    Bernard, Sophie
    Goldwirt, Lauriane
    Amorim, Sandy
    Brice, Pauline
    Briere, Josette
    de Kerviler, Eric
    Mourah, Samia
    Sauvageon, Helene
    Thieblemont, Catherine
    BLOOD, 2015, 126 (14) : 1695 - 1698
  • [10] Ibrutinib for the treatment of mantle cell lymphoma
    Shah, Nimish
    Hutchinson, Claire
    Rule, Simon
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (05) : 521 - 531
12345